Aims To characterise milk/plasma (M/P) ratio and infant exposure, for sertraline and N-desmethylsertraline, in breast-feeding women taking sertraline for the treatment of depression. Methods Eight women (mean age 28 years) taking sertraline (1.05 mg kg −1 day −1 ) and their infants (mean age 5.7 months) were studied. Sertraline and Ndesmethylsertraline in plasma and milk were measured by high-performance liquid chromatography over a 24 h dose interval at steady-state. M/P values were estimated from area under the plasma and milk concentration-time curves. All milk produced was collected over the dose interval. Infant exposure was estimated as the product of actual or estimated milk production, and average drug concentration in milk, normalized to body weight and expressed as a percentage of the weight-adjusted maternal dose. Results Mean milk production was 321 ml day −1 (range 34-974 ml). Mean M/P values of 1.93 and 1.64 were calculated for sertraline and N-desmethylsertraline respectively. Infant exposure estimated from actual milk produced was 0.2% and 0.3% of the weight-adjusted maternal dose for sertraline and N-desmethylsertraline (as sertraline equivalents) respectively. When calculated from estimated milk production (0.15 l kg −1 day −1 ), infant exposure was significantly greater ( P<0.0001) at 0.90% and 1.32% for sertraline and N-desmethylsertraline respectively. Neither sertraline nor its N-desmethyl metabolite could be detected in plasma samples from the four infants tested. No adverse effects were observed in any of the eight infants and all had achieved normal developmental milestones. Conclusions Irrespective of the method of calculation of infant exposure, the mean total dose of sertraline and its N-desmethyl metabolite transmitted to infants via breast-feeding is low and unlikely to cause any significant adverse effects.
Introduction characterisation of the transfer of drugs into human milk involves the measurement of milk/plasma (M/P) distribution Depression affects some 3 to 12% of the population each year, and is approximately twice as frequent in women as ratio and the average concentration of drug in milk over a dose interval [7] . Ideally, these data should be obtained by men [1, 2] . The rate of new psychiatric episodes in women increases markedly in the first 3 months after childbirth, measurement of areas under the milk and plasma concentration-time curves (AUC) at steady state [8] . Using this with between 10 and 15% of mothers experiencing depression [3] . Sertraline is a derivative of naphthylamine experimental design, the present study measured M/P ratios and mean infant exposure for sertraline and its major that belongs to the selective serotonin (5-HT) reuptake inhibitor (SSRI) group of antidepressants [4] . The SSRIs metabolite N-desmethylsertraline. are being prescribed increasingly for the treatment of postnatal depression, posing a dilemma for mothers who wish to breast-feed their infants, but who are concerned Methods about the infant's exposure to the medication. Published information on the distribution of sertraline into human Materials milk is limited to a single case report [5] and 2.4% at 0.04 and 0.4 mg 1 −1 respectively (n=8) for NEight breast-feeding women, and their infants were enrolled in the study. The women's mean age was 27.9 years (range desmethylsertraline. Aliquots of milk were analysed by the method of addition so as to avoid differential variation in 23.9-31.6 years) and their mean body weight was 71.1 kg (range 54.0-105.0 kg). Seven of the women were maintained recovery of sertraline or N-desmethylsertraline and desipramine that may occur when milk samples having differing on a single daily oral dose of 50 mg sertraline whilst the eighth was taking 200 mg sertraline once daily. Their infants composition are extracted. Desipramine (internal standard; 200 ng in 0.02 ml of an aqueous solution) was added to (six males and two females) had a mean body weight of 7.93 kg (range 4.95-11.3 kg) and were a mean of 5.7 months 0.5 ml aliquots of milk in 10 ml disposable polypropylene tubes. Each sample was assayed in quadruplicate with the of age (range 1.8-14.2 months) at the time of the study. Therapy with sertraline had commenced a mean of 2.1 addition of 0, 100, 150 and 200 mg 1 −1 of sertraline or Ndesmethylsertraline respectively. Sodium tetraborate (1 ml of months (range 1.18-4.25 months) prior to the study day and all participants were considered to be at steady-state. 2% w/v; pH 9.2) was added to each tube and the samples were extracted as described above for plasma. For each individual sample a standard curve relating added sertraline Study protocol or N-desmethylsertraline concentration and peak height ratio (sertraline or N-desmethylsertraline5desipramine) was The study design was approved by the Research and Ethics Committees of the King Edward Memorial Hospital, Centre constructed and the concentration of sertraline or Ndesmethylsertraline in the sample was obtained from the for Women's Health. Written informed consent was obtained from all participants. The women were admitted to the x-axis intercept. The within-run CVs for the milk assay were 9.5 and 9.7% at 0.05 and 0.4 mg 1 −1 respectively for research ward at 07.30 h, and had an intravenous cannula inserted into a forearm vein prior to the morning dose of sertraline and 6.7% and 8.9% at 0.05 and 0.4 mg 1
respectively for N-desmethylsertraline (n=7). H.p.l.c. analysertraline at 08.00 h. Venous blood samples (8 ml) were collected from the cannula into heparinised tubes, at 0, 1, 2, ses were carried out on a system comprising a GBC Model LC 1610 Autosampler, Waters 6000A Solvent Delivery 3, 4, 6 and 8 h post dose, and by venepuncture at 12 and 24 h. At the same time intervals both breasts were emptied System, Waters 486 Tunable u.v. Absorbance Detector set at 210 nm and a Goerz Model SE120 BBC chart recorder. via an electric or manual breast pump and the volume of milk was recorded. Samples of milk (15 ml) were retained Analytes were separated on a Beckman UltraspherA Octyl C 8 column (5 mm; 4.6 mm×25 cm) using a mobile phase for drug assay and the remainder made available to bottle feed the infants. The women were discharged from hospital of 43% v/v acetonitrile in an aqueous solution containing 0.086% w/v 1-octanesulphonic acid and 0.01% v/v NNNNafter the 8 h samples and milk and plasma samples at 12 and 24 h post dose were collected by a research assistant who tetramethylenediamine (adjusted to final pH 2.5 with H 3 PO 4 ), pumped at a flow rate of 1.6 ml min −1 . visited the patient at home. The infants were fed with stored breast milk for the duration of the study. Four women gave consent for a heparinised venous blood sample (0.5-1 ml) to Calculation of infant dose be taken from their infant for subsequent drug assay.
The absolute infant sertraline or N-desmethylsertraline (as sertraline equivalents) dose was calculated by two separate H.p.l.c. analysis of sertraline and N-desmethylsertraline in methods, both assuming an oral bioavailability of 100%. In plasma and milk method A, the measured cumulative drug excretion over 24 h was divided by the infant's body weight to give a dose Aliquots of plasma (0.5 ml) were mixed with desipramine (internal standard; 200 ng in 0.02 ml of an aqueous solution) in mg kg
. In method B, an average infant intake of 0.15 l milk kg −1 day −1 was assumed [9] , and this value was in 10 ml screw-capped disposable polypropylene tubes. Sodium tetraborate (1 ml of 2% w/v; pH 9.2) was added to multiplied by the average milk concentration (AUC milk /dose interval time) to give a dose in mg kg −1
. For both methods, the plasma and the samples were extracted with 8 ml of isopropylether by shaking vigorously for 5 min. After the infant dose was then expressed as a percentage of the maternal weight-normalised dose. centrifugation (5 min at 1500 g), the organic phase was aspirated to a clean tube and the compounds back-extracted AUC(0,24 h) for the plasma and milk concentration-time profiles was calculated using the trapezoidal rule. Oral into 0.2 ml of 0.1 m H 3 PO 4 by shaking vigorously for 5 min. After further 5 min centrifugation, the organic phase plasma clearance of sertraline was calculated as dose/ AUC plasma 0-24 h . was aspirated and discarded. The uncapped aqueous acid phase was centrifuged for 10 min at 1500 g. The sample was then placed under a stream of N 2 in a water bath at 50°C
Statistical evaluation of data for 30 s to remove the last traces of isopropylether. Aliquots (0.08 ml) were injected directly onto the h.p.l.c. Unknown
Data have been summarised as mean±s.e.mean or mean (range) as appropriate. Differences between means were samples were interpolated from a linear plot of the peak height ratio for drug5desipramine vs known concentrations assessed using Student's t-test. and 1.32±0.15% for N-desmethylsertraline. Mean values Results for Method B were significantly higher than those for Method A for both sertraline (t=6.7, P<0.0001) and NTypical plasma and milk concentration-time data and cumulative milk excretion for sertraline and N-desmethylserdesmethylsertraline (t=5.9, P<0.0001). The concentrations of both sertraline and N-desmethylsertraline were less than traline are shown for patient 1, in Figure 1 a and b respectively. The mean total volume of milk collected from 5 mg l −1 ( limit of detection) in the four infants whose blood was sampled (Table 2 ). All infants in the study appeared to the patients over the 24 h period of the study was 321 ml (range 34-974 ml). Volunteer 5 was able to produce only be feeding well and achieving the normal developmental milestones, which were assessed by examination of the very small amounts of milk. Table 1 outlines the maternal dose, AUC for the milk Personal Health Record book of each infant and discussion with the mother. No drug-related or other adverse effects and plasma concentration-time curves for both sertraline and N-desmethylsertraline, and the M/P ratio values derived were reported by the mothers. from this data for both analytes. Mean oral plasma clearance of sertraline was 1.72±0.21 l h −1 . The mean M/P ratios Discussion calculated from AUC data for sertraline and N-desmethylsertraline were 1.93±0.16 and 1.64±0.19 respectively.
After oral administration, sertraline is slowly absorbed, with peak concentrations occurring after 6-8 h [10] . Sertraline Table 2 summarizes the calculated infant dose of sertraline and N-desmethylsertraline as sertraline equivalents. Infant has a volume of distribution of 20 l kg −1 , and is approximately 99% bound to plasma proteins [10] . It undergoes dose was calculated by two different methods. The mean absolute infant doses calculated by Method A, using actual sequential oxidation and conjugation in the liver and is excreted mainly as metabolites in urine and faeces [10] . The cumulative drug excretion, were 0.20%± 0.05% for sertraline and 0.30%±0.09% for N-desmethylsertraline.
primary metabolite, N-desmethylsertraline, is formed by cytochrome P4503A4. It has approximately eight times less Doses calculated by Method B, assuming an estimated infant intake of 0.15 l kg −1 day −1 were 0.90±0.09% for sertraline activity than sertraline in the inhibition of 5-HT uptake and N-desmethysertraline in milk (+). Table 1 Maternal dose, AUC for plasma and milk and M/P ratios for sertraline and N-desmethylsertraline. in vitro and is inactive in animal models of depression and Prolactin secretion is also mediated by serotonin, with raised serum prolactin levels reported in some patients treated with other in vivo tests [10] . The half-life (t 1/2 ) of sertraline is 25-26 h, while that for the N-desmethyl metabolite ranges SSRIs [17] . The M/P ratios measured in this study for sertraline and N-desmethylsertraline were high (1.9 and 1.6 from 66-80 h [10] .
The plasma concentrations of sertraline and N-desmethylrespectively), but within the range of values for basic amines with similar pKa values [18] . The range of M/P values for sertraline, and the oral clearance of sertraline, for our patients, were similar to previously reported values [11, 12] . sertraline (1.14-2.55) in our study is considerably higher than the value of 0.63 which can be calculated from the The total milk volumes (mean 321±108 ml day −1 ) measured in this study were low by comparison with the range data in the single case reported by Altshuler et al. [5] . However, this latter calculation may be unreliable as it is of 700-800 ml day −1 reported by others [9, 13] and the mean of 726±134 ml day −1 which we reported in a study based on the average of several milk concentrations divided by a single observation of plasma sertraline concentration. of the distribution and excretion of sumatriptan into human milk [14] . Sertraline and/or its metabolites, the underlying Infant dose was calculated by two different methods. Method B, which assumes an average milk intake of depressive illness, and individual variability in physiological control factors are possible contributors to the low milk 0.15 l kg −1 day −1 gave mean values that were approximately 4-fold higher than those calculated by Method A which was volumes. An inefficient pumping technique, or the possibility that an infant may have been breast fed during the evening, based on actual total milk production volumes. Nevertheless, it should be noted that on average infants only consume may have also affected the volume of milk collected. It is of interest to note that sertraline has modest ability (K i = some 76% of the available milk [19] . The lower values for method A probably reflect total milk collection volumes at 260 nm) to block the uptake of [ 3 H]-dopamine in rat brain synaptosomes [15] . Since the secretion of prolactin by the the low end of the expected normal range, together with the abnormally low milk volumes obtained from volunteer anterior hypothalamus is sensitive to D 2 -receptor activation [16] and since mean plasma concentrations of sertraline were 5. In the context of total dose of pharmacologically active drug received by the infant via the milk, the difference around 1000 nm in our study, it is possible that sertraline itself is in part responsible for the low milk production rate.
between methods A and B is of little practical significance.
